• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于感染性糖尿病足溃疡诊断的五聚体蛋白-3及其他炎症标志物:一项前瞻性研究

Pentraxin-3 and Other Inflammatory Markers for an Infected Diabetic Foot Ulcer Diagnosis: A Prospective Study.

作者信息

Ardelean Andrei, Balta Diana-Federica, Neamtu Carmen, Neamtu Adriana Andreea, Rosu Mihai, Pilat Luminita, Moldovan Silviu, Tarta Cristi, Totolici Bogdan

机构信息

1st Surgery Clinic, Faculty of Medicine, West University "Vasile Goldis" Arad, 310025 Arad, Romania.

Faculty of Medicine, West University "Vasile Goldis" Arad, 310025 Arad, Romania.

出版信息

Diagnostics (Basel). 2023 Jul 13;13(14):2366. doi: 10.3390/diagnostics13142366.

DOI:10.3390/diagnostics13142366
PMID:37510110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10377911/
Abstract

Strategies have been researched and implemented to reduce the number of people with diabetic foot ulcers (DFUs). One problem is the accurate assessment of DFU severity, which is the main factor in resource allocation and treatment choice. The primary objective of this study was to assess pentraxin-3 as a biomarker of an infected DFU (IDFU), the limb amputation level prognosis, and patient survival. The secondary objectives were to evaluate and compare other markers, including white blood cells (WBCs), C-reactive protein (CRP), the erythrocyte sedimentation rate (ESR), and procalcitonin (PCT), for identifying IDFUs. Over a period of two years, 145 patients were followed; 131 of these were analyzed for this study. Pentraxin-3 was found to be a good predictor of death ( = 0.047). A comparison between IDFUs and DFUs revealed the following differences: PCT had the highest AUROC of 0.91, sensitivity of 93.7, and specificity of 83.3%. CRP had a cutoff value of 226 mg/L, an AUROC of 0.89, a sensitivity of 95.5%, and a specificity of 83.3%. Fibrinogen had an AUROC of 0.87 at a cutoff value of 5.29 g/L, with a good sensitivity and specificity of 85% and 87%, respectively. ESR had a cutoff value of 46 mm/h, an AUROC of 85%, a sensitivity of 83.7%, and a specificity of 83.3%. Pentraxin-3 showed promising results in predicting IDFUs and DFUs, and it served as a marker for the risk of death in IDFU patients during the 6 month follow-up. Other markers, including CRP, PCT, ESR, and fibrinogen, were more effective in differentiating between IDFUs and DFUs.

摘要

已经研究并实施了减少糖尿病足溃疡(DFU)患者数量的策略。一个问题是DFU严重程度的准确评估,这是资源分配和治疗选择的主要因素。本研究的主要目的是评估五聚体-3作为感染性DFU(IDFU)的生物标志物、肢体截肢水平预后和患者生存率。次要目的是评估和比较其他标志物,包括白细胞(WBC)、C反应蛋白(CRP)、红细胞沉降率(ESR)和降钙素原(PCT),以识别IDFU。在两年的时间里,对145名患者进行了随访;其中131名患者纳入本研究进行分析。发现五聚体-3是死亡的良好预测指标(P = 0.047)。IDFU与DFU之间的比较显示出以下差异:PCT的曲线下面积(AUROC)最高,为0.91,敏感性为93.7%,特异性为83.3%。CRP的临界值为226 mg/L,AUROC为0.89,敏感性为95.5%,特异性为83.3%。纤维蛋白原在临界值为5.29 g/L时AUROC为0.87,敏感性和特异性分别为85%和87%,表现良好。ESR的临界值为46 mm/h,AUROC为85%,敏感性为83.7%,特异性为83.3%。五聚体-3在预测IDFU和DFU方面显示出有前景的结果,并且在6个月的随访期间作为IDFU患者死亡风险的标志物。包括CRP、PCT、ESR和纤维蛋白原在内的其他标志物在区分IDFU和DFU方面更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d6/10377911/c1a1ec7953bd/diagnostics-13-02366-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d6/10377911/1894235f8870/diagnostics-13-02366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d6/10377911/2b4c837c8f50/diagnostics-13-02366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d6/10377911/2dc839dd2d9d/diagnostics-13-02366-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d6/10377911/c1a1ec7953bd/diagnostics-13-02366-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d6/10377911/1894235f8870/diagnostics-13-02366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d6/10377911/2b4c837c8f50/diagnostics-13-02366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d6/10377911/2dc839dd2d9d/diagnostics-13-02366-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d6/10377911/c1a1ec7953bd/diagnostics-13-02366-g004.jpg

相似文献

1
Pentraxin-3 and Other Inflammatory Markers for an Infected Diabetic Foot Ulcer Diagnosis: A Prospective Study.用于感染性糖尿病足溃疡诊断的五聚体蛋白-3及其他炎症标志物:一项前瞻性研究
Diagnostics (Basel). 2023 Jul 13;13(14):2366. doi: 10.3390/diagnostics13142366.
2
Can procalcitonin be an accurate diagnostic marker for the classification of diabetic foot ulcers?降钙素原能否作为糖尿病足溃疡分类的准确诊断标志物?
Int J Endocrinol Metab. 2014 Jan 5;12(1):e13376. doi: 10.5812/ijem.13376. eCollection 2014 Jan.
3
The Role of Serum Procalcitonin, Interleukin-6, and Fibrinogen Levels in Differential Diagnosis of Diabetic Foot Ulcer Infection.血清降钙素原、白细胞介素-6 和纤维蛋白原水平在糖尿病足溃疡感染鉴别诊断中的作用。
J Diabetes Res. 2018 Feb 21;2018:7104352. doi: 10.1155/2018/7104352. eCollection 2018.
4
Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers.循环降钙素原作为生物标志物反映南印度糖尿病足溃疡炎症的潜力。
J Vasc Surg. 2018 Apr;67(4):1283-1291.e2. doi: 10.1016/j.jvs.2017.02.060. Epub 2017 Jul 21.
5
Is Procalcitonin more superior to hs-CRP in the diagnosis of infection in diabetic foot ulcer?降钙素原在诊断糖尿病足溃疡感染方面是否优于超敏 C 反应蛋白?
Malays J Pathol. 2020 Apr;42(1):77-84.
6
Pro-Calcitonin, Erythrocyte Sedimentation Rate and C - reactive Protein in Predicting Diabetic Foot Ulcer Characteristics; a Cross Sectional Study.降钙素原、红细胞沉降率和C反应蛋白在预测糖尿病足溃疡特征中的作用;一项横断面研究。
Arch Acad Emerg Med. 2019 Jul 10;7(1):37. eCollection 2019.
7
Comparative Evaluation of the Diagnostic Value of Procalcitonin and hsCRP for the Presence of Mild-to-Moderate Diabetic Foot Infections.降钙素原与超敏C反应蛋白对轻至中度糖尿病足感染诊断价值的比较评估
Int J Low Extrem Wounds. 2023 Jun;22(2):353-359. doi: 10.1177/15347346211011849. Epub 2021 Apr 28.
8
Serum Procalcitonin (PCT) - Is there a Role as an Early Biomarker in Infected Diabetic Foot Ulcer (IDFU) Patients?血清降钙素原(PCT)——在感染性糖尿病足溃疡(IDFU)患者中作为早期生物标志物有作用吗?
Malays Orthop J. 2023 Jul;17(2):62-69. doi: 10.5704/MOJ.2307.010.
9
The efficacy of inflammatory markers in diagnosing infected diabetic foot ulcers and diabetic foot osteomyelitis: Systematic review and meta-analysis.炎症标志物在诊断感染性糖尿病足溃疡和糖尿病足骨髓炎中的疗效:系统评价和荟萃分析。
PLoS One. 2022 Apr 27;17(4):e0267412. doi: 10.1371/journal.pone.0267412. eCollection 2022.
10
The role of procalcitonin as a marker of diabetic foot ulcer infection.降钙素原作为糖尿病足溃疡感染标志物的作用。
Int Wound J. 2017 Feb;14(1):31-34. doi: 10.1111/iwj.12536. Epub 2015 Oct 28.

引用本文的文献

1
Pentraxin-3 as a Biomarker in Diabetes Mellitus: Insights into Inflammation, Vascular Complications, and Modulation by Antidiabetic Medications.作为糖尿病生物标志物的3型补体蛋白:对炎症、血管并发症及抗糖尿病药物调节作用的见解
Biomedicines. 2025 Apr 7;13(4):891. doi: 10.3390/biomedicines13040891.
2
Pentraxin-3 and Outcomes in CKD: A Systematic Review and Meta-analysis.CKD中五聚体蛋白-3与结局:一项系统评价和Meta分析
Kidney Med. 2024 Feb 22;6(4):100800. doi: 10.1016/j.xkme.2024.100800. eCollection 2024 Apr.

本文引用的文献

1
The efficacy of inflammatory markers in diagnosing infected diabetic foot ulcers and diabetic foot osteomyelitis: Systematic review and meta-analysis.炎症标志物在诊断感染性糖尿病足溃疡和糖尿病足骨髓炎中的疗效:系统评价和荟萃分析。
PLoS One. 2022 Apr 27;17(4):e0267412. doi: 10.1371/journal.pone.0267412. eCollection 2022.
2
Triage Strategies Based on C-Reactive Protein Levels and SARS-CoV-2 Tests among Individuals Referred with Suspected COVID-19: A Prospective Cohort Study.基于C反应蛋白水平和严重急性呼吸综合征冠状病毒2检测的新型冠状病毒肺炎疑似转诊患者分诊策略:一项前瞻性队列研究
J Clin Med. 2021 Dec 30;11(1):201. doi: 10.3390/jcm11010201.
3
Inflammatory Biomarkers as Predictors of Infected Diabetic Foot Ulcer.
炎症生物标志物作为感染性糖尿病足溃疡的预测指标
Curr Diabetes Rev. 2022;18(6):e280921196867. doi: 10.2174/1573399817666210928144706.
4
Is Procalcitonin more superior to hs-CRP in the diagnosis of infection in diabetic foot ulcer?降钙素原在诊断糖尿病足溃疡感染方面是否优于超敏 C 反应蛋白?
Malays J Pathol. 2020 Apr;42(1):77-84.
5
Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update).糖尿病足感染的诊断和治疗指南(IWGDF 2019 更新)。
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3280. doi: 10.1002/dmrr.3280.
6
Definitions and criteria for diabetic foot disease.糖尿病足病的定义和标准。
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3268. doi: 10.1002/dmrr.3268. Epub 2020 Jan 14.
7
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives.炎症在糖尿病中的作用:当前概念与未来展望
Eur Cardiol. 2019 Apr;14(1):50-59. doi: 10.15420/ecr.2018.33.1.
8
Pentraxin-3: A new parameter in predicting the severity of diabetic foot infection?Pentraxin-3:预测糖尿病足感染严重程度的新参数?
Int Wound J. 2019 Jun;16(3):659-664. doi: 10.1111/iwj.13075. Epub 2019 Feb 15.
9
Mortality in patients with diabetic foot ulcer: a retrospective study of 513 cases from a single Centre in the Northern Territory of Australia.糖尿病足溃疡患者的死亡率:对澳大利亚北领地一个中心的513例病例的回顾性研究。
BMC Endocr Disord. 2019 Jan 3;19(1):1. doi: 10.1186/s12902-018-0327-2.
10
Incidence and Risk Factors of Diabetic Foot Ulcer: A Population-Based Diabetic Foot Cohort (ADFC Study)-Two-Year Follow-Up Study.糖尿病足溃疡的发病率及危险因素:一项基于人群的糖尿病足队列研究(ADFC研究)——两年随访研究
Int J Endocrinol. 2018 Mar 15;2018:7631659. doi: 10.1155/2018/7631659. eCollection 2018.